Overview
Evaluation of adherence, persistence and efficacy of treatment with PCSK9 inhibitors in a real-life Italian population.
Eligibility
Inclusion Criteria:
- Patients under PCSK9 inhibitor treatment.
Exclusion Criteria:
- Age < 18 years o > 80 years;
- Patients who refuse to participate and to sign informed consent.